Endpoints News 2026-01-20 Exciva raises $59M Series B to fund Phase 2 test of Alzheimer’s agitation drug
Illumina 2026-01-20 The Bull Case For Illumina (ILMN) Could Change Following Its Billion Cell Atlas Pharma Alliance - Yahoo Finance Singapore
Agilent 2026-01-20 Nucleotide Market Is Going to Boom | Agilent Technologies • Bio-Rad Laboratories • QIAGEN - openPR.com
Waters 2026-01-20 Is Waters Corporation the Quiet Wall Street Cheat Code Everyone’s Sleeping On? - AD HOC NEWS
Agilent 2026-01-19 Profit Recap: Is Agilent Technologies Inc showing insider buying - Quarterly Earnings Summary & AI Driven Stock Price Forecasts - baoquankhu1.vn
FierceBiotech 2026-01-19 FDA Grants RMAT Designation to iRegene’s NouvNeu001, Cementing its Lead as the World’s First iPSC Therapy with Both FTD and RMAT Recognitions
FierceBiotech 2026-01-19 AstraZeneca pens $630M pact to secure remaining rights to armored CAR-T from AbelZeta
Thermo Fisher 2026-01-19 Thermo Fisher Scientific Inc.: BCC Research Releases Comprehensive 360° Company Analysis - Yahoo Finance
Thermo Fisher 2026-01-19 The Zacks Analyst Blog Highlights Visa, Advanced Micro Devices and Thermo Fisher Scientific - Zacks Investment Research
BioWorld 2026-01-19 Nanjing Chia Tai Tianqing Pharmaceutical identifies new somatostatin SST2 receptor agonists
FierceBiotech 2026-01-19 Immunology biotech Agomab, eye-focused SpyGlass are latest biotechs to share IPO ambitions
Agilent 2026-01-19 Agilent Technologies, Inc. (NYSE:A) S&P 500 Today Global Lab Support - Kalkine Media